Free. Unsubscribe any time.
ANAPTYSBIO, INC (ANAB)
ANAPTYSBIO, INC filed 12 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 21 transactions and 124,931 shares. None carries the SEC's AFF10B5ONE flag; all 12 name a plan in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-02-13, came 36 days after the one before it (2026-01-08) and reports 3 transactions against 8 in the filing before it.
- The sales it reports total 10,000 shares, 361 more than the 9,639 in the filing before it.
- Its 12 plan statements rank 358th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 4 have more plan statements on file than it and 6 have fewer.
- Its 12 filings on file run from 2025-06-20 to 2026-02-13, and state 4 plan adoption dates, from 2024-03-14 to 2025-04-14.
Trades in ANAPTYSBIO, INC 21
- FENTON DENNIS M — 2025-06-18 · S · 3,015 shares
- RENTON HOLLINGS — 2025-06-18 · S · 3,015 shares
- RENTON HOLLINGS — 2025-07-02 · S · 7,250 shares
- RENTON HOLLINGS — 2025-07-02 · S · 13,675 shares
- RENTON HOLLINGS — 2025-08-08 · S · 3,110 shares
- RENTON HOLLINGS — 2025-08-08 · S · 7,121 shares
- LOUMEAU ERIC J — 2025-09-30 · S · 8,240 shares
- LOUMEAU ERIC J — 2025-12-16 · S · 8,305 shares
- LOUMEAU ERIC J — 2025-12-16 · S · 4,195 shares
- MULROY DENNIS — 2025-12-16 · S · 9,365 shares
- MULROY DENNIS — 2025-12-16 · S · 6,360 shares
- LOUMEAU ERIC J — 2025-12-17 · S · 10,000 shares
Adoption dates in ANAPTYSBIO, INC 4
- 2024-03-14 — stated in 3 filings
- 2024-03-22 — stated in 1 filing
- 2025-04-11 — stated in 7 filings
- 2025-04-14 — stated in 1 filing
Results prints in ANAPTYSBIO, INC 7
- 2025-02-27
- 2025-05-05
- 2025-08-06
- 2025-11-04
- 2026-01-09
- 2026-03-03
- 2026-05-12
Trades before a print in ANAPTYSBIO, INC 4
- 2 days before the 2026-01-09 print — 2026-01-07 · S · LOUMEAU ERIC J · 2,017 shares
- 2 days before the 2026-01-09 print — 2026-01-07 · S · LOUMEAU ERIC J · 5,281 shares
- 2 days before the 2026-01-09 print — 2026-01-07 · S · LOUMEAU ERIC J · 1,841 shares
- 2 days before the 2026-01-09 print — 2026-01-07 · S · LOUMEAU ERIC J · 500 shares
- 18 days before the 2026-01-09 print — 2025-12-22 · S · LOUMEAU ERIC J · 10,000 shares
- 18 days before the 2026-01-09 print — 2025-12-22 · S · Lizzul Paul F. · 1,500 shares
- 18 days before the 2026-01-09 print — 2025-12-22 · S · MULROY DENNIS · 10,000 shares
- 20 days before the 2026-03-03 print — 2026-02-11 · S · LOUMEAU ERIC J · 10,000 shares
- 22 days before the 2026-01-09 print — 2025-12-18 · S · LOUMEAU ERIC J · 141 shares
- 23 days before the 2026-01-09 print — 2025-12-17 · S · LOUMEAU ERIC J · 10,000 shares
- 24 days before the 2026-01-09 print — 2025-12-16 · S · LOUMEAU ERIC J · 8,305 shares
- 24 days before the 2026-01-09 print — 2025-12-16 · S · LOUMEAU ERIC J · 4,195 shares
Interval to ANAPTYSBIO, INC’s next reported results date
How the interval and sources are counted →
- 4within 5 days
- 4within 10 days
- 2shortest, days
- 0no later print
- LOUMEAU ERIC J 2026-01-07 · S · 2 days before the 2026-01-09 print · CHIEF LEGAL OFFICER
- LOUMEAU ERIC J 2026-01-07 · S · 2 days before the 2026-01-09 print · CHIEF LEGAL OFFICER
- LOUMEAU ERIC J 2026-01-07 · S · 2 days before the 2026-01-09 print · CHIEF LEGAL OFFICER
- LOUMEAU ERIC J 2026-01-07 · S · 2 days before the 2026-01-09 print · CHIEF LEGAL OFFICER
Adoption dates ANAPTYSBIO, INC states
- 2024-03-14 in 3 filings
- 2024-03-22 in 1 filing
- 2025-04-11 in 7 filings
- 2025-04-14 in 1 filing
Filing text: “10b5-1 trading plan adopted by the reporting person dated April 11, 2025”
Reported results dates on file
- 2025-02-27
- 2025-05-05
- 2025-08-06
- 2025-11-04
- 2026-01-09
- 2026-03-03
- 2026-05-12
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.